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isolate more phages in Brazil and
neighboring countries. 
To date, serotyping is the only
identification tool for the characteri-
zation of non-O1 strains of V. choler-
ae (8). However, serotyping is only
performed at a limited number of lab-
oratories. For this study, all isolates
from Brazil were sent to laboratories
outside the country for serotyping.
This step was expensive and time-
consuming and posed risks during
transit.
An alternative method is the use of
phages for identifying non-O1 strains.
This method offers an affordable
monitoring system in less-developed
countries such as Brazil. Phage O6
and O34 should at least be useful for
confirming the diagnosis of V. choler-
ae O6 and O34 infection and for dif-
ferentiating V. cholerae O1 and non-
O1 strains. 
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Salmonella Agona
Harboring Genomic
Island 1-A
To the Editor: Multidrug-resistant
Salmonella enterica serovar
Typhimurium definitive phage type
104 has emerged during the 1980s and
1990s as a world health problem
because of its implications in animal
and human disease (1–3). Epidemic
serovar Typhimurium definitive
phage type 104 isolates are common-
ly resistant to ampicillin (Ap), chlo-
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Figure 1. Electron micro-
graph of O34 vibriophage.
Bar represents 100 nm.
Figure 2. Electron micro-
graph of O6 vibriophage.
Bar represents 100 nm.LETTERS
ramphenicol (Cm)/florfenicol (Ff),
streptomycin (Sm)/spectinomycin
(Sp), sulfonamides (Su), and tetracy-
clines (Tc) (1,3). This multidrug-
resistance phenotype is conferred by
an antibiotic resistance gene cluster
included in a 43kb genomic island
named Salmonella genomic island 1
(4). Salmonella genomic island 1 has
been recently characterized and locat-
ed between the thdF and int2 genes of
the chromosome. The int2 gene is part
of a retron sequence found only in
serovar Typhimurium. Downstream
of the retron sequence is the yidY
gene, which is also found in the chro-
mosome of other S. enterica serovars.
The antibiotic resistance gene cluster
of approximately 13 kb is located at
the 3' end of Salmonella genomic
island 1 (4). All resistance genes are
clustered and are bracketed by two
integron structures (5,6). The first
integron carries the aadA2 gene,
which confers resistance to Sm and
Sp. The second integron contains the
β-lactamase gene pse-1, conferring
resistance to Ap. Flanked by these two
integron structures are the floR gene,
which confers cross-resistance to Cm
and Ff, and the tetracycline-resistance
genes tetR and tet(G) (5,6). Recently,
Salmonella genomic island 1 has also
been identified in other serovars of S.
enterica namely Agona (4,7),
Paratyphi B (8), and Albany (9), indi-
cating the horizontal transfer potential
of  Salmonella genomic island 1. In
these serovars, Salmonella genomic
island 1 has the same chromosomal
location as in serovar Typhimurium
definitive phage type 104, except that
they lack the retron sequence found
downstream of Salmonella genomic
island 1 (4,8,9). Moreover, six variant
Salmonella genomic island 1 antibiot-
ic resistance gene clusters
(Salmonella genomic island 1-A to -
F) have recently been reported for
serovars Typhimurium DT104,
Agona, and Albany to confer different
multidrug resistance phenotypes
(9,10). These clusters of genes were
probably generated after chromoso-
mal recombinational events or by
antibiotic resistance gene cassette
replacement in the integron structures.
In particular, the dfrA10 gene coding
for trimethoprim (Tm) resistance was
found downstream of the pse-1 inte-
gron in a third unusual integron struc-
ture involving orf513 in the variant
antibiotic resistance gene cluster
called Salmonella genomic island 1-A
(ApCmFfSmSpSuTcTm) (10).
Multidrug-resistant serovar
Typhimurium definitive phage type
104 was disseminated globally with
several outbreaks in humans and ani-
mals. At present, in contrast to the
world health problem of multidrug-
resistant serovar Typhimurium defini-
tive phage type 104, human cases of
infections with other S. enterica
serovars harboring Salmonella
genomic island 1 have not yet been
reported. Salmonella genomic island
1-multidrug-resistant serovars Agona,
Paratyphi B, and Albany were isolated
from different animal species and
countries (7–9). In this study, we
analysed the first Salmonella genomic
island 1 positive serovar Agona strain
(02/01177) isolated from a human
case in Belgium.
A Belgian patient, who had been
infected by a multidrug-resistant
serovar Agona strain was travelling to
Turkey; subsequent to the multidrug-
resistant serovar Agona strain, gas-
troenteritis developed. While in
Turkey the patient sought medical
care and was treated unsuccessfully
with antimicrobial agents. Upon his
return to Belgium, this serovar Agona
strain was isolated from his stools,
and he recovered after treatment with
ciprofloxacin. The serovar Agona
strain 02/01177 displayed the mul-
tidrug resistance profile ApCmFfSm
SpSuTcTm, which suggested the pos-
sible occurrence of Salmonella
genomic island 1-A (10). Moreover,
the strain showed the same level of
resistance to Ff as Salmonella genom-
ic island 1 harboring S. enterica
serovars (MIC of 64 µg/mL) (7–9). 
To assess the presence of
Salmonella genomic island 1 and its
location in the chromosome, poly-
merase chain reactions (PCRs) were
performed using primers correspon-
ding to the left and the right (with or
without retron) Salmonella genomic
island 1 junctions to the chromosome
as described previously (4,8–10).
PCR results were positive for the left
junction between the thdF gene of the
chromosome and the int gene of
Salmonella genomic island 1 (4). For
the right junction, PCR results were
positive between open reading frame
(ORF) S044 of Salmonella genomic
island 1 and yidY gene of the chromo-
some. Thus, these data indicate that
this serovar Agona human isolate con-
tains Salmonella genomic island 1 at
the same chromosomal location as in
other  Salmonella genomic island 1
positive serovars but lacks the retron
sequence found to date only in serovar
Typhimurium strains (4,8,9). 
PCR mapping of the typical antibi-
otic resistance genes and integrons
associated with Salmonella genomic
island 1 was realized as described pre-
viouly (4,8–10). PCR amplifications
on genomic DNA extracted from
serovar Agona strain 02/01177 yield-
ed all specific fragments of the sizes
expected from DNAof serovar Agona
control strain 1169SA97 harboring
Salmonella genomic island 1-A (data
not shown) (10). These PCR mapping
results indicated the presence of the
typical Salmonella genomic island 1
resistance gene cluster with the inser-
tion of the third unusual orf513 inte-
gron structure carrying dfrA10 (8–10).
These data are in accordance with the
multidrug resistance phenotype of
serovar Agona strain 02/01177 and
indicate the presence of the variant
antibiotic resistance gene cluster
Salmonella genomic island 1-A (10).
Macrorestriction analysis by
pulsed-field gel electrophoresis of
DNA from serovar Agona strain
02/01177 cut by XbaI or BlnI, showed
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that this human isolate is indistin-
guishable by its XbaI or BlnI macrore-
striction patterns from the other mul-
tidrug-resistant  Salmonella genomic
island 1-carrying serovar Agona
strains isolated from poultry in
Belgium (data not shown) (7). Thus,
the human serovar Agona isolate
appears clonally related to those from
poultry.
To our knowledge, this is the first
report describing a human infected by
a serovar Agona strain harboring
Salmonella genomic island 1-A.
Moreover, it shows the first case
where another S. enterica serovar har-
boring Salmonella genomic island 1
than the epidemic serovar
Typhimurium definitive phage type
104 clone is implicated in human
infection. The patient could probably
have been infected before his travel to
Turkey by a Salmonella genomic
island 1-A carrying serovar Agona
strain in Belgium where this type of
strain is frequently isolated from
poultry (Doublet et al., pers. comm.).
This hypothesis is also supported by
macrorestriction analysis, which
showed that the strains from poultry
and the human case-patient had iden-
tical  XbaI and BlnI pulsed-field gel
electrophoresis patterns and thus indi-
cate that they are clonally related.
Moreover, the patient was not in con-
tact with poultry during his stay in
Turkey and, to date, very little is
known about the epidemiology of
multidrug-resistant serovar Agona
strains in this country. Further investi-
gations on the epidemiology of mul-
tidrug-resistant serovar Agona strains
harboring Salmonella genomic island
1 are warranted to avoid such strains
becoming a worldwide epidemic, as
was the case for multidrug-resistant
serovar Typhimurium definitive
phage type 104.
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